Guan Sheng, Zhou Kang-rong, Zhao Wei-dong, Peng Wei-jun, Tang Feng, Mao Jian
Department of Radiology, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
Chin Med J (Engl). 2005 Apr 20;118(8):639-44.
The diagnosis of diffuse hepatic lesions in early stage is a tough task at any time for clinical conventional imaging. Magnetic resonance diffusion-weighted imaging (MR DWI) can detect the changes of tissue structure at molecular level. This study was designed to determine the value of DWI in the diagnosis of diffuse liver lesions in early stage.
Diffuse liver lesions were induced by diethylnitrosamine in 42 rats of test group. Fourteen rats in control group were fed with pure water. Dynamic changes of MR DWI were observed every week in both groups during the early stage of diffuse liver lesions (1 to 12 weeks after drug administration in the test group). Apparent diffusion coefficient (ADC) values of liver parenchyma in different stages and pathologic changes were analyzed.
The process of diffuse hepatic lesions in the test group was classified into three stages according to pathological changes, namely hepatitis, hepatic fibrosis and cirrhosis. No obvious morphological changes were shown by conventional imaging in both groups during this stage. But MR DWI demonstrated heterogeneous signal changes in early stage of hepatic cirrhosis in the test group. No significant change of ADC values was found in the control group between different weeks (P > 0.05). The ADC values of the test group declined from the fifth week, and after the tenth week the ADC values were significantly different between the test and control groups at gradient factor (b) value 300 sec/mm(2) (P < 0.05). At b value 600 and 1000 sec/mm(2), significant difference was seen between the two groups from the sixth week onward. The range of ADC value of the groups was (1.7 - 0.9) +/- (0.40 - 0.04) mm(2)/sec (b = 600) and (1.38 - 0.75) +/- (0.07 - 0.35) mm(2)/sec (b = 1000), respectively. Dominant pathological changes included swelled hepatocytes within 1 to 4 weeks after the administration of diethylnitrosamine in the test group, hyperplasia of fibrous tissues in 5 - 8 weeks and formation of cirrhotic nodules in 9 - 12 weeks.
MR functional DWI could detect diffuse liver lesions earlier than conventional morphological imaging. ADC value as a marker for early diagnosis of diffuse liver lesions could also be used to inspect changes of the lesions.
对于临床常规影像学检查而言,早期诊断弥漫性肝脏病变一直是一项艰巨的任务。磁共振扩散加权成像(MR DWI)能够在分子水平检测组织结构的变化。本研究旨在确定DWI在早期诊断弥漫性肝脏病变中的价值。
试验组42只大鼠经二乙基亚硝胺诱导产生弥漫性肝脏病变。对照组14只大鼠喂以纯水。在弥漫性肝脏病变早期(试验组给药后1至12周),两组每周均观察MR DWI的动态变化。分析不同阶段肝脏实质的表观扩散系数(ADC)值及病理变化。
试验组弥漫性肝脏病变过程根据病理变化分为三个阶段,即肝炎、肝纤维化和肝硬化。在此阶段,两组常规影像学检查均未显示明显形态学变化。但试验组在肝硬化早期MR DWI显示信号不均匀改变。对照组不同周之间ADC值无显著变化(P>0.05)。试验组ADC值从第5周开始下降,第10周后,在梯度因子(b)值为300 sec/mm²时,试验组与对照组ADC值有显著差异(P<0.05)。在b值为600和1000 sec/mm²时,从第6周起两组间有显著差异。两组ADC值范围分别为(1.7 - 0.9)±(0.40 - 0.04)mm²/sec(b = 600)和(1.38 - 0.75)±(0.07 - 0.35)mm²/sec(b = 1000)。主要病理变化包括试验组在给予二乙基亚硝胺后1至4周肝细胞肿胀,5至8周纤维组织增生,9至12周形成肝硬化结节。
MR功能DWI比传统形态学成像能更早检测出弥漫性肝脏病变。ADC值作为弥漫性肝脏病变早期诊断的标志物,也可用于观察病变的变化。